Mitsui Chemicals, Inc.

Satoshi Ichimura, president of Mitsui Chemicals, has laid out a management policy centered on restructuring the petrochemical business and expanding growth areas in life and healthcare, mobility, and ICT. Ichimura, who took office as president in April 2026, said that after the U.S. and Israeli attacks on Iran, the company set up an emergency response meeting in March, switched naphtha procurement to regions outside the Middle East, and kept operations going with information provided by the Ministry of Economy, Trade and Industry and the Ministry of Foreign Affairs. In petrochemicals, the company will consolidate ethylene production at a single plant in Chiba Prefecture in eastern Japan together with Idemitsu Kosan in 2027, and in western Japan will consolidate the plants of Asahi Kasei and Mitsubishi Chemical at its Osaka works into one. Overseas sales account for about half of the total, and roughly 70 percent of sales in the growth areas. In dental materials, the company decided in June to acquire Ultradent, a U.S. dental materials maker that is the world leader in whitening, for about 140 billion yen.